Onsdag 28 Oktober | 18:14:48 Europe / Stockholm
Est. tid*
2026-11-12 07:00 Kvartalsrapport 2026-Q3
2026-08-19 - Kvartalsrapport 2026-Q2
2026-05-15 - Kvartalsrapport 2026-Q1
2026-04-24 - X-dag ordinarie utdelning LIFE 0.00 NOK
2026-04-23 - Årsstämma
2026-03-03 - Bokslutskommuniké 2025
2026-01-02 - Extra Bolagsstämma 2026
2025-11-12 - Extra Bolagsstämma 2025
2025-11-12 - Kvartalsrapport 2025-Q3
2025-08-20 - Kvartalsrapport 2025-Q2
2025-05-15 - Kvartalsrapport 2025-Q1
2025-04-28 - X-dag ordinarie utdelning LIFE 0.00 NOK
2025-04-25 - Årsstämma
2025-02-20 - Bokslutskommuniké 2024
2024-11-13 - Kvartalsrapport 2024-Q3
2024-10-01 - Split LIFE 13:1
2024-08-27 - Kvartalsrapport 2024-Q2
2024-05-16 - Extra Bolagsstämma 2024
2024-05-08 - Kvartalsrapport 2024-Q1
2024-05-02 - X-dag ordinarie utdelning LIFE 0.00 NOK
2024-04-30 - Årsstämma
2024-02-27 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-11 - Kvartalsrapport 2023-Q1
2023-05-08 - X-dag ordinarie utdelning LIFE 0.00 NOK
2023-04-18 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-09 - X-dag ordinarie utdelning LIFE 0.00 NOK
2022-05-06 - Årsstämma
2022-04-21 - Bokslutskommuniké 2021
2021-09-30 - Extra Bolagsstämma 2021
2021-08-05 - Kvartalsrapport 2021-Q2
2021-05-10 - X-dag ordinarie utdelning LIFE 0.00 NOK
2021-05-07 - Årsstämma
2021-04-20 - Bokslutskommuniké 2020
2020-06-26 - Årsstämma
2020-06-01 - Bokslutskommuniké 2019
2019-02-07 - Split LIFE 4:1
2018-12-11 - Extra Bolagsstämma 2018
LandNorge
ListaOslo Bors
SektorHälsovård
IndustriMedicinteknik
Lifecare är ett norskt bolag verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av microsensorer för diabetes. Mikrosensorerna injiceras under huden på patientens handled, och fungerar vidare som en realtidsuppdatering av glukosnivån i patienten. Utöver bidrar tekniken med larmsensor samt tillgång till historisk data över patientens glukosnivå. Bolaget etablerades år 2006 och har sitt huvudkontor i Bergen, Norge.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Lifecare Employee Share Purchase Program – Subscriptions by Primary Insiders - Increase of share capital

2022-07-15 13:35:25
Bergen, Norway 15.7.22

Reference is made to Stock Exchange Announcement 23 May 2022 regarding the establishment of Lifecare Group incentive program. 

All employees in the Lifecare Group have been invited to participate in Lifecares Employee Share Purchase Program 2022 and individually subscribe for up to 20 000 shares with a 25% discount off the volume weighted average share price (VWAP) calculated 10 days prior to end of the subscription period (30 June 2022).

9 employees in the Lifecare Group have accepted to participate and subscribed for in total 124 719 shares, of which the primary insiders Joacim Holter (Lifecare CEO) and Prof. Andreas Pfützner (Lifecare CSO) both have subscribed for the maximum offering of 20 000 shares. 

The price per share under Lifecares Employee Share Purchase Program 2022 has been calculated to NOK 3,22962, taking the VWAP and discount into consideration. All shares under the Lifecare Employee Share Purchase Program 2022 have a lock up period of 12 months. 

Based on board authorization granted by the General Meeting of Lifecare 6 May 2022, Lifecares’ Board of Directors passed a resolution to issue 124 719 shares for an aggregated subscription price of NOK 402 794,98, corresponding to a price per share of NOK 3,22962.  

Following the issuance of the new shares, the Company will have 99 865 742 shares outstanding, each with a nominal value of NOK 0,40. The total share capital of the Company will be NOK 39 946 296,20. The Company’s Articles of Associations will be updated accordingly.   

The share issuance is expected to be completed by 15. August 2021. 

Further information
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Joacim Holter, CEO at Lifecare AS, on 15.7.2022 at 13:35 CET.